Kirk Christopher J. 4
4 · Kezar Life Sciences, Inc. · Filed Jan 7, 2022
Insider Transaction Report
Form 4
Kirk Christopher J.
DirectorCEO
Transactions
- Award
Employee Stock Option (right to buy)
2022-01-05+170,000→ 170,000 totalExercise: $14.55Exp: 2032-01-04→ Common Stock (170,000 underlying)
Footnotes (1)
- [F1]One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on January 5, 2022, subject to the Reporting Person continuing to provide service through each such date.